fluorouracil has been researched along with transforming growth factor alpha in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bianco, AR; Ciardiello, F; De Luca, A; Normanno, N; Pepe, S; Salomon, DS; Sandomenico, C; Selvam, MP | 1 |
| Kitaura, K; Kumagai, K; Kusada, O; Mochizuki, Y; Terai, Y; Ueda, M; Ueki, K; Ueki, M; Yamada, N | 1 |
| Erwin, CR; Huang, FS; Kemp, CJ; Warner, BW; Williams, JL | 1 |
| Willett, CG; Zhu, AX | 1 |
| Bang, YJ; Cha, Y; Ham, HS; Han, SW; Im, SA; Im, YH; Kim, HP; Kim, TY; Lee, KS; Oh, DY; Park, IH; Park, JW; Rhee, J; Ro, J | 1 |
| Kanwar, SS; Majumdar, AP; Nautiyal, J; Oh, PS; Patel, BB; Patel, VB; Sanders, MA; Yu, Y | 1 |
| Ahuja, A; Chan, AT; Chan, C; Chan, SL; Dattatray, RD; Ho, WM; Hui, EP; King, AD; Lau, W; Ma, BB; Mo, F; Poon, A; To, KF; Wong, SC | 1 |
| Bai, Y; Liang, J; Liu, H; Shen, L; Wang, J; Xu, J; Xu, N; Yang, L; Zhang, X | 1 |
1 review(s) available for fluorouracil and transforming growth factor alpha
| Article | Year |
|---|---|
Combined modality treatment for rectal cancer.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Camptothecin; Capecitabine; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclooxygenase Inhibitors; Deoxycytidine; Fluorouracil; Humans; Irinotecan; Organoplatinum Compounds; Oxaliplatin; Radiotherapy, Adjuvant; Rectal Neoplasms; Transforming Growth Factor alpha | 2005 |
2 trial(s) available for fluorouracil and transforming growth factor alpha
| Article | Year |
|---|---|
Intermittent versus continuous erlotinib with concomitant modified "XELOX" (q3W) in first-line treatment of metastatic colorectal cancer: correlation with serum amphiregulin and transforming growth factor alpha.
Topics: Adult; Aged; Amphiregulin; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Deoxycytidine; Drug Administration Schedule; EGF Family of Proteins; Erlotinib Hydrochloride; Female; Fluorouracil; Glycoproteins; Humans; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Mutation; Neoplasm Metastasis; Oxaloacetates; Patient Compliance; Prognosis; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Quinazolines; ras Proteins; Transforming Growth Factor alpha | 2013 |
Predictive biomarkers for the efficacy of cetuximab combined with cisplatin and capecitabine in advanced gastric or esophagogastric junction adenocarcinoma: a prospective multicenter phase 2 trial.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Capecitabine; Cetuximab; Cisplatin; Deoxycytidine; ErbB Receptors; Esophagogastric Junction; Female; Fluorouracil; Gene Dosage; Humans; Male; Middle Aged; Prospective Studies; Stomach Neoplasms; Transforming Growth Factor alpha; Treatment Outcome; Young Adult | 2014 |
5 other study(ies) available for fluorouracil and transforming growth factor alpha
| Article | Year |
|---|---|
Anti-sense oligonucleotides directed against EGF-related growth factors enhance anti-proliferative effect of conventional anti-tumor drugs in human colon-cancer cells.
Topics: Amphiregulin; Antineoplastic Agents; Cell Division; Cisplatin; Colonic Neoplasms; DNA, Neoplasm; Doxorubicin; Drug Combinations; Drug Synergism; EGF Family of Proteins; Epidermal Growth Factor; Flow Cytometry; Fluorouracil; Glycoproteins; GPI-Linked Proteins; Growth Substances; Humans; Intercellular Signaling Peptides and Proteins; Membrane Glycoproteins; Mitomycin; Neoplasm Proteins; Oligonucleotides, Antisense; RNA, Messenger; Thionucleotides; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1997 |
Regulation of dihydropyrimidine dehydrogenase and pyrimidine nucleoside phosphorylase activities by growth factors and subsequent effects on 5-fluorouracil sensitivity in tumor cells.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cell Division; Dihydrouracil Dehydrogenase (NADP); Drug Synergism; Epidermal Growth Factor; Female; Fluorouracil; Humans; Oxidoreductases; Pentosyltransferases; Pyrimidine Phosphorylases; Transforming Growth Factor alpha; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2000 |
Role of epidermal growth factor and its receptor in chemotherapy-induced intestinal injury.
Topics: Animals; Antineoplastic Agents; Enteritis; Epidermal Growth Factor; ErbB Receptors; Fluorouracil; Gene Expression; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Mice, Transgenic; Microvilli; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor alpha | 2002 |
High serum TGF-α predicts poor response to lapatinib and capecitabine in HER2-positive breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Capecitabine; Cell Line, Tumor; Cell Proliferation; Chi-Square Distribution; Deoxycytidine; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Enzyme-Linked Immunosorbent Assay; Female; Fluorouracil; Humans; Kaplan-Meier Estimate; Lapatinib; Logistic Models; Middle Aged; Quinazolines; Receptor, ErbB-2; Republic of Korea; Risk Assessment; Risk Factors; Time Factors; Transforming Growth Factor alpha; Treatment Outcome; Up-Regulation | 2011 |
Schlafen-3 decreases cancer stem cell marker expression and autocrine/juxtacrine signaling in FOLFOX-resistant colon cancer cells.
Topics: AC133 Antigen; Aldehyde Dehydrogenase 1 Family; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Autocrine Communication; Cell Adhesion Molecules, Neuronal; Cell Cycle Proteins; Cell Differentiation; Colonic Neoplasms; Drug Resistance, Neoplasm; ErbB Receptors; Fetal Proteins; Fluorouracil; Glycoproteins; HCT116 Cells; HT29 Cells; Humans; Hyaluronan Receptors; Isoenzymes; Leucovorin; Neoplasm Proteins; Neoplastic Stem Cells; Organoplatinum Compounds; Peptides; Proteins; Retinal Dehydrogenase; RNA, Messenger; Signal Transduction; Transfection; Transforming Growth Factor alpha | 2011 |